CD133+ liver cancer stem cells resist interferon-gamma-induced autophagy

BACKGROUND: Hepatocellular carcinoma (HCC) is one of the most fatal malignancies worldwide, and CD133 is a popular cancer stem cell (CSC) marker for HCC. CD133(+) CSCs have been reported to resist conventional chemo- and radiotherapy, but little is known about their response to immune surveillance....

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jian, Chen, Jin-Na, Zeng, Ting-Ting, He, Fan, Chen, Shu-Peng, Ma, Stephanie, Bi, Jiong, Zhu, Xiao-Feng, Guan, Xin-Yuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711109/
https://www.ncbi.nlm.nih.gov/pubmed/26758620
http://dx.doi.org/10.1186/s12885-016-2050-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4711109/
https://www.ncbi.nlm.nih.gov/pubmed/26758620
http://dx.doi.org/10.1186/s12885-016-2050-6

Ejemplares similares